Vollherbst, Dominik F. http://orcid.org/0000-0002-8992-4757
Chapot, René http://orcid.org/0000-0002-9245-0636
Bendszus, Martin http://orcid.org/0000-0002-9094-6769
Möhlenbruch, Markus A. http://orcid.org/0000-0002-5075-704X
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 20 May 2021
Accepted: 1 July 2021
First Online: 29 July 2021
Conflict of interest
: D.F. Vollherbst has received travel support outside this work from MicroVention, Stryker and Cerenovus. R. Chapot is consultant and/or proctor for BALT, Stryker, Microvention, Rapid Medical, Siemens Medical Systems. M. Bendszus reports board membership: DSMB Vascular Dynamics; consultancy: Roche, Guerbet, Codman; grants/grants pending: DFG, Hopp Foundation, Novartis, Siemens, Guerbet, Stryker, Covidien; payment for lectures (including service on speakers bureaus): Novartis, Roche, Guerbet, Teva, Bayer, Codman. M.A. Möhlenbruch has received consulting fees, speaker fees, and travel support outside this work from Codman, Covidien/Medtronic, MicroVention, Phenox, and Stryker.